Product Code: VPHS27614
This new report from VPGMarketResearch.com contains 411 pages, 28 tables, and presents a comprehensive analysis of the US hospital hemostasis diagnostic testing market, including:
Major issues pertaining to the US hospital coagulation laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.
Profiles of major current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
Contains 411 pages and 28 tables
Table of Contents
Worldwide Market and Technology Overview
A. Major Routine and Special Coagulation Tests
- 1. Introduction
- 2. Activated Partial Thromboplastin Time (APTT)
- 3. Alpha-2 Antiplasmin
- 4. Antithrombin III
- 5. Bleeding Time
- 6. D-Dimer
- 7. Ethanol Flocculation Test
- 8. Euglobulin Lysis
- 9. Factor Assays
- a. Introduction
- b. Factor II
- c. Factor V/Factor V Leiden
- d. Factor VII
- e. Factor VIII
- f. Factor IX
- g. Factor IXa
- h. Factor X (Stuart Factor)
- i. Factor Xa
- j. Factor XI
- k. Factor XII
- l. Factor XIII
- 10. Fibrin Degradation Products
- 11. Fibrinogen
- 12. Heparin
- 13. Hirudin
- 14. Hypercoagulability and Thrombosis
- 15. Lipoprotein a
- 16. Plasmin
- 17. Plasminogen
- 18. Plasminogen Activator Inhibitor (PAI)
- 19. Platelet Function Tests
- 20. Platelet Aggregation
- 21. Proteins C and S
- 22. Prothrombin Fragment 1.2
- 23. Prothrombin Time (PT)
- 24. Reptilase Time
- 25. Thrombin Time
- 26. Tissue-Type Plasminogen Activator (t-PA)
- 27. Von Willebrand's Factor
B. Instrumentation Review
- Introduction
- Benk Hemolab
- Benk TRT Thrombotimer
- Bio/Data MCA 310
- Bio/Data MCA 210
- Bio/Data PAP-4C D/4D/4C
- Cardiovascular Diagnostics COAG
- Diagnostica Stago STA Compact
- Diagnostica Stago STA-R
- Diagnostica Stago Star 4/8
- Helena Laboratories Cascade 480
- Helena Laboratories Cascade M
- Helena Laboratories PACKS-4
- Helena THOR
- Instrumentation Laboratory ACL 100 and 1000 series
- Instrumentation Laboratory ACL6000
- Instrumentation Laboratory ACL7000
- Instrumentation Laboratory ACL9000
- Instrumentation Laboratory Electra 1000C
- Instrumentation Laboratory Electra 1400C
- Instrumentation Laboratory Electra 1600/C
- Instrumentation Laboratory Electra 1800C
- Instrumentation Laboratory Futura
- ITC Hemochron 8000
- Roche Diagnostics CoaguChek
- Siemens BCS
- Siemens BCT
- Siemens BF II/Fibrintimer Series
- Sysmex CA-50
- Sysmex CA-500
- Sysmex CA-1500
- Sysmex CA-5000/CA-1000
- Sysmex CA-6000
- Sysmex CA-7000
- Teco Coatron II/Jr./AccuStasis 5000
- Trinity Biotech Amax CS190
- Trinity Biotech Amax CS400
- Trinity Biotech Coag-A-Mate Max
- Trinity Biotech KC 40, 4A, 1A Series
- Trinity Biotech MDA 180
- Trinity Biotech Coag-A-Mate MTX
- Trinity Biotech Coag-A-Mate RA4
- Trinity Biotech Coag-A-Mate XC/Plus
- Trinity Biotech Coag-A-Mate XM
C. Major in Vitro Diagnostic Technologies and Their Potential Applications
- 1. Chromogenic Substrates
- 2. Monoclonal and Polyclonal Antibodies
- 3. Immunoassays
- a. Applications
- b. Technological Principle
- c. Enzyme Immunoassays (EIA)
- Overview
- ELISA
- EMIT
- Dot Immunobinding Assays
- Capillary Immunoassays
- Enzyme Amplification
- Electrochemical Immunoassay
- d. Fluorescent Immunoassays
- Fluorescence Polarization
- Time-Resolved Pulse Fluorescence
- Fluorescence Lifetime
- e. Latex Agglutination
- f. Immunoprecipitation
- 4. Microcomputers
- 5. Automation
- 6. Robotics
- 7. DNA Probes
- a. Overview
- b. Amplification Methods
- PCR
- Ligase Chain Reaction
- Branched DNA
- Q-Beta Replicase
- NASBA
- SDA
- 3 SR
- HPA
- Two-Tiered System
- LAT
- 8. Artificial Intelligence
- 9. Dry Chemistry
- 10. Biosensors
USA
- A. Executive Summary
- B. Business Environment
- 1. Health Care Expenditures
- 2. Cost Consciousness
- 3. Industry Consolidation
- 4. Managed Care
- 5. Hospitals
- 6. Admissions
- 7. Length of Stay
- 8. Industry Diversification
- 9. Physician Demographics
- 10. Population Aging
- a. Chronic Illnesses
- b. Disease Incidence
- c. Susceptibility to Iatrogenesis
- d. Multiple Illness Cases
- 11. Laboratory Regulations
C. Market Structure
- 1. Centralized Testing
- a. Hospitals
- b. Commercial laboratories
- 2. Decentralized Testing
- a. Physician Offices/Group Practices
- b. Point-of-Care Testing
- c. Home/Self Testing
- d. Other Decentralized Testing Locations
D. Market Size, Growth And Major Suppliers
Major Product Development Opportunities
Design Criteria For Decentralized Testing Products
Alternative Market Penetration Strategies
- A. Internal Development
- B. Collaborative Arrangements
- C. University Contracts
- D. Distribution Strategies for Decentralized Testing Markets
- 1. Marketing Approaches
- 2. Product Complexity
- 3. Customer Preference
- 4. Established Suppliers
- 5. Emerging Suppliers
- 6. Major Types Of Distributors
- 7. Market Segmentation
Potential Market Entry Barriers And Risks
- A. Market Maturity
- B. Cost Containment
- C. Competition
- D. Technological Edge And Limitations
- E. Patent Protection
- F. Regulatory Constraints
- G. Decentralized Testing Market Challenges
Competitive Assessments
- Abbott
- American Diagnostica
- Avocet Medical
- Axis-Shield
- Beckman Coulter
- Becton Dickinson
- Bio/Data Corporation
- Biosite
- Chrono-Log
- Corgenix Medical
- Diagnostica Stago
- Helena Laboratories
- HYPEN BioMed
- Instrumentation Laboratory
- ITC
- Nanogen
- Roche
- Siemens
- Sienco
- Sysmex
- Thermo Fischer
- Trinity Biotech
- ZyCare
List of Tables
- Major Companies Developing or Marketing Activated Clotting Time Tests
- Major Companies Developing or Marketing APTT Tests
- Major Companies Developing or Marketing Alpha-2 Antiplasmin Tests
- Major Companies Developing or Marketing Antithrombin III Tests
- Major Companies Developing or Marketing Bleeding Time Tests
- Major Companies Developing or Marketing D-dimer Tests
- Major Companies Developing or Marketing Factor Assays
- Major Companies Developing or Marketing Fibrin Degradation Product Tests
- Major Companies Developing or Marketing Fibrinogen Tests
- Major Companies Developing or Marketing Heparin Tests
- Major Companies Developing or Marketing Plasmin Tests
- Major Companies Developing or Marketing Plasminogen Tests
- Major Companies Developing or Marketing Plasminogen Activator Inhibitor
Tests
- Major Companies Developing or Marketing Platelet Aggregation Tests
- Major Companies Developing or Marketing Protein C Tests
- Major Companies Developing or Marketing Protein S Tests
- Major Companies Developing or Marketing PT Tests
- Major Companies Developing or Marketing Thrombin Time Tests
- Major Companies Developing or Marketing TPA Tests
- Major Companies Developing or Marketing Von Willebrand's Factor Tests
- Executive Summary Table: U.S.A., Hospital Coagulation Diagnostics
- Market By Product Category
- U.S.A., Hospital Laboratories Performing Coagulation Tests By Bed Size
- U.S.A., Hospital Laboratories Average Daily Test Volume
- U.S.A., Hospital Laboratories Coagulation Test Volume by Assay
- U.S.A., Major Suppliers of Coagulation Reagents, Estimated Sales and
Market Shares
- U.S.A., Major Suppliers of Coagulation Analyzers, Estimated Sales and
Market Shares
- U.S.A., Coagulation Diagnostics Market By Product Category
- U.S.A., Major Suppliers of Coagulation Diagnostic Products, Estimated
Sales and Market Shares
